ArticleBreast cancer research and treatment2025

Antitumor activity of the combination of vinorelbine and gemcitabine in patients with HR + /HER2- advanced breast cancer after CDK4/6 inhibitor.

Pablo Jara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.